Sylvester Comprehensive Cancer Center has once again been recognized as a Cancer Center of Excellence by the State of Florida — one of just four cancer centers in the state, and the only one in South Florida, to have earned this honor. The designation recognizes providers that exceed service standards and excel in providing quality, comprehensive and patient-centered, coordinated care for cancer patients in Florida.
Sylvester Provides 100 Patients Potentially Life-Saving Treatments in its Phase 1 Trial Program 02.14.2018
Dr. Jaime Merchan is thrilled that Sylvester Comprehensive Cancer Center has reached the milestone number of 100 patients enrolled in a single year in its Phase 1 clinical trials program. The program, which tests new drugs and other novel treatment strategies for advanced solid tumors and hematological malignances, offers these patients something they couldn’t find elsewhere: hope.
Sarah Sukkar vividly remembers the phone call from the University of Miami Leonard M. Miller School of Medicine. At the other end of the phone, an admissions officer was telling her that not only had she been accepted into the medical school’s Class of 2020, but that she’d been awarded a scholarship too. The second-year M.D. candidate expressed her gratitude at the 2018 Medical Education Donors and Scholars Luncheon.
A collaborative U01 grant titled “Unifying Templates, Ontologies and Tools to Achieve Effective Annotation of Bioassay Protocols” has been awarded to the University of Miami together with Stanford University and Collaborative Drug Discovery. The principal investigators of this $2,088,678 U01 grant are Stephan Schürer of the UM Miller School of Medicine, Mark Musen of Stanford, and Barry Bunin at Collaborative Drug Discovery.
UM Researcher Joins New NIH Partnership to Promote Organization of Big Data in Biomedicine 02.14.2018
The University of Miami Miller School of Medicine is joining a partnership to combine advances in ontologies, templates and other research tools to take digital biomedical research data to the next level. The National Institutes of Health has awarded a $2,088,678 U01 grant to be shared under a cooperative agreement between Stephan Schürer, Ph.D., and colleagues at Stanford University and Collaborative Drug Discovery.
Florida Blue has renewed its Blue Distinction Center for Transplants designation for the adult bone marrow transplant program at Sylvester Comprehensive Cancer Center. The renewed designation is recognition that the program at Sylvester, part of UHealth – the University of Miami Health System, continues to meet the insurer’s national standards for high quality care and outcomes.
A cross-disciplinary group of researchers at the University of Miami Miller School of Medicine has found that allogeneic adipose-derived mesenchymal stromal cells (ASCs) will prevent lung and skin fibrosis, and restore wound healing.
Four generations of the Kapnek-Zasloff family took part in the eighth annual Dolphins Cancer Challenge on Saturday to support the life-saving work of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Throughout the day, thousands of South Floridians shared hugs, smiles and a few tears in recalling their loved ones during the DCC VIII celebration at Hard Rock Stadium.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine welcomed the State of Florida’s Chief Financial Officer, Jimmy Patronis, on February 5, giving him a tour of its cancer-fighting technologies. Patronis also met with representatives from more than a dozen of South Florida’s fire departments whose members are collaborating with Sylvester’s Firefighters Cancer Initiative.
Sylvester and Brazil’s Barretos Cancer Hospital Sign Agreement for Collaborative Research 02.06.2018
Sylvester Comprehensive Cancer Center and Barretos Cancer Hospital — one of the most advanced public hospital cancer centers in Brazil — signed a memorandum of understanding on February 2 for wide-ranging collaborative research that may begin by the end of this year. Representatives from Barretos traveled to Miami to sign the agreement, meet with Sylvester researchers and clinicians, and tour Sylvester’s facilities.